Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|11 Sep 2012||Submitted||Original manuscript|
|16 Oct 2012||Reviewed||Reviewer Report - Oliver Renner|
|17 Oct 2012||Reviewed||Reviewer Report - David Cano|
|22 Oct 2012||Reviewed||Reviewer Report - Francisco X. Real|
|24 Oct 2012||Reviewed||Reviewer Report - Pamela Crowell|
|10 Dec 2012||Author responded||Author comments - Michele Yip-Schneider|
|Resubmission - Version 2|
|10 Dec 2012||Submitted||Manuscript version 2|
|17 Jan 2013||Reviewed||Reviewer Report - David Cano|
|23 Feb 2013||Reviewed||Reviewer Report - Francisco X. Real|
|22 Mar 2013||Author responded||Author comments - Michele Yip-Schneider|
|Resubmission - Version 3|
|22 Mar 2013||Submitted||Manuscript version 3|
|11 Apr 2013||Editorially accepted|
|17 Apr 2013||Article published||10.1186/1471-2407-13-194|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.